Mark A. Velleca, President and CEO at G1 Therapeutics, Inc. (GTHX), sold 9,985 shares at $39.84 ($398K) on 2018-11-15, disclosed to the SEC on 2018-11-16.
Open-market sale of $398k GTHX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.84 | 4,985 | $199K | 49.9% |
| 2 | $39.84 | 4,985 | $199K | 49.9% |
| 3 | $40.59 | 15 | $609 | 0.2% |
| Total | $39.84 avg | 9,985 | $398K | 100% |
| Filing → |
| GTHX | SELL | 2022-09-22 | $270K | — | Filing → |
| GTHX | SELL | 2022-08-18 | $1.0M | — | Filing → |
| GTHX | SELL | 2021-07-15 | $946K | — | Filing → |